Related Funds
Funds with similar focus
Fund Name | Location |
10x Value Partners | England, London, United Kingdom |
Aegon Industrial Fund Management Co. | - |
BitScale | - |
Bonjour Holdings | China, Hong Kong, New Territories |
CICC Jiacheng Investment Management | Beijing, Beijing, China |
Credit Suisse Loan Funding | - |
Finance Birmingham | Birmingham, England, United Kingdom |
GSX | Japan, Tokyo |
Incubio | Barcelona, Catalonia, Spain |
Korea Venture Investment Corp | Seoul, Seoul-t'ukpyolsi, South Korea |
Schmidt Family Foundation | - |
Shenzhen Capital Fortune Investment Management | China, Guangdong, Shenzhen |
Tsingbay Venture Capital | China, Guangdong, Shenzhen |
Tsunagu Solutions | Japan, Tokyo |
Yuxin Jiuding (Xiamen) Touzi Guanli Zhongxin | - |
Zhejiang Xianju Pharmaceutical | China, Jiangsu, Taizhou |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Endocyte | $15M | 26 Mar 2007 | Indiana, United States | ||
RedPath Integrated Pathology | $6M | 20 Dec 2006 | Pittsburgh, Pennsylvania, United States | ||
EKOS Corporation | $26M | 21 Mar 2006 | Washington, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Endocyte | $15M | 26 Mar 2007 | Indiana, United States | ||
RedPath Integrated Pathology | $6M | 20 Dec 2006 | Pittsburgh, Pennsylvania, United States | ||
EKOS Corporation | $26M | 21 Mar 2006 | Washington, United States |